GREGORY D PERRY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY D PERRY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY D PERRY. GREGORY D PERRY is See Remarks in QLT INC/BC ($QLTI) and Sr. VP & CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and VP, Finance & CEO in TRANSKARYOTIC THERAPIES INC ($TKTX) and VP, Finance and CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and Director in Ocata Therapeutics, Inc. ($ACTC) and in Aegerion Pharmaceuticals, Inc. ($AEGR) and Chief Financial Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and See Remarks in Aegerion Pharmaceuticals, Inc. ($AEGR) and in Kala Pharmaceuticals, Inc. ($KALA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Chief Financial and Business in Eleven Biotherapeutics, Inc. ($EBIO) and Chief Financial Officer in Finch Therapeutics Group, Inc. ($FNCH).
Latest Insider Trading Transactions of GREGORY D PERRY
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, FNCH, KALA, NVLN, ACTC, SESN, TKTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 21 2021 | KALA | Kala Pharmaceutica ... | PERRY GREGORY D | Grant | A | 0.00 | 20,000 | 0 | 40,000 | 20 K to 40 K (+100.00 %) | |
| Mar 18 2021 | FNCH | Finch Therapeutics ... | PERRY GREGORY D | Chief Financial Off ... | Option Exercise | A | 17.00 | 55,386 | 941,562 | 55,386 | |
| Jun 29 2020 | KALA | Kala Pharmaceutica ... | PERRY GREGORY D | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Jun 07 2019 | KALA | Kala Pharmaceutica ... | PERRY GREGORY D | Director | Option Exercise | A | 5.35 | 21,000 | 112,350 | 21,000 | |
| Mar 02 2018 | KALA | Kala Pharmaceutica ... | PERRY GREGORY D | Director | Option Exercise | A | 14.05 | 25,920 | 364,176 | 25,920 | |
| May 11 2017 | QLTI | NOVELION THERAPEUT ... | PERRY GREGORY D | See Remarks | Option Exercise | M | 0.00 | 2,393 | 0 | 4,786 | |
| May 11 2017 | QLTI | NOVELION THERAPEUT ... | PERRY GREGORY D | See Remarks | Payment of Exercise | F | 9.42 | 710 | 6,688 | 1,683 | 2.4 K to 1.7 K (-29.67 %) |
| May 11 2017 | QLTI | NOVELION THERAPEUT ... | PERRY GREGORY D | See Remarks | Buy | M | 0.00 | 2,393 | 0 | 2,393 | 0 to 2.4 K |
| Dec 27 2016 | QLTI | NOVELION THERAPEUT ... | PERRY GREGORY D | See Remarks | Option Exercise | A | 8.65 | 166,020 | 1,436,073 | 166,020 | |
| Dec 01 2016 | QLTI | QLT INC/BC | PERRY GREGORY D | See Remarks | Option Exercise | A | 0.00 | 35,896 | 0 | 35,896 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 0.00 | 35,000 | 0 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 2.46 | 69,000 | 169,740 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 5.71 | 200,000 | 1,142,000 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 19.52 | 40,000 | 780,800 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 19.58 | 200,000 | 3,916,000 | 0 | ||
| May 11 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | See Remarks | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
| May 11 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | See Remarks | Option Exercise | A | 2.46 | 69,000 | 169,740 | 69,000 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 8.36 | 5,000 | 41,800 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 6.39 | 5,000 | 31,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 6.17 | 5,000 | 30,850 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 5.79 | 5,000 | 28,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 9.00 | 5,000 | 45,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 10.37 | 417 | 4,324 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Sell | U | 8.50 | 21,417 | 182,045 | 0 | 21.4 K to 0 (-100.00 %) |
| Feb 17 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | See Remarks | Option Exercise | A | 5.71 | 200,000 | 1,142,000 | 200,000 | |
| Jan 04 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | A | 8.36 | 5,000 | 41,800 | 5,000 | |
| Jan 04 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Grant | A | 0.00 | 1,250 | 0 | 21,417 | 20.2 K to 21.4 K (+6.20 %) |
| Oct 01 2015 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Grant | A | 0.00 | 1,250 | 0 | 20,167 | 18.9 K to 20.2 K (+6.61 %) |
| Aug 06 2015 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Chief Financial Off ... | Option Exercise | A | 19.52 | 40,000 | 780,800 | 40,000 | |
| Aug 04 2015 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Chief Financial Off ... | Option Exercise | A | 19.58 | 200,000 | 3,916,000 | 200,000 | |
| Jul 02 2015 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Grant | A | 0.00 | 1,250 | 0 | 18,917 | 17.7 K to 18.9 K (+7.08 %) |
| Apr 01 2015 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Grant | A | 0.00 | 1,250 | 0 | 17,667 | 16.4 K to 17.7 K (+7.61 %) |
| Feb 27 2015 | EBIO | Eleven Biotherapeu ... | PERRY GREGORY D | Chief Financial and ... | Option Exercise | A | 10.39 | 57,500 | 597,425 | 203,248 | |
| Mar 28 2005 | TKTX | TRANSKARYOTIC THER ... | PERRY GREGORY D | Sr. VP & CFO | Option Exercise | A | 23.79 | 15,000 | 356,850 | 15,000 | |
| Nov 15 2004 | TKTX | TRANSKARYOTIC THER ... | PERRY GREGORY D | VP, Finance and CFO | Option Exercise | A | 21.74 | 32,500 | 706,550 | 32,500 | |
| Mar 26 2004 | TKTX | TRANSKARYOTIC THER ... | PERRY GREGORY D | VP, Finance & CEO | Option Exercise | A | 10.62 | 8,959 | 95,145 | 8,959 |
Page: 1